Value Sense
ACN
Accenture plc (ACN)
Last Price$345.0(1.0%)
Market Cap$218.7B
LTM Research & Development Expenses (R&D)
$0.0
YoY Growth
-100.0%
3Y CAGR
-100.0%
5Y CAGR
-100.0%
Stock quality & Intrinsic value
7/10
17.4% overvalued
ACN
is (17.4%) overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

Accenture plc Research & Development Expenses (R&D)

Annual
Quarterly
LTM
Crunching data... Almost there!
Aug'05Aug'06Aug'07Aug'08Aug'09Aug'10Aug'11Aug'12Aug'13Aug'14Aug'15Aug'16Aug'17Aug'18Aug'19Aug'20Aug'21Aug'22Aug'23Aug'24
Research & Development Expenses (R&D)
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$0.0
$715.1M
$639.5M
$625.5M
$643.4M
$704.3M
$790.8M
$799.7M
$870.6M
$1,118.3M
$1,123.3M
$1,298.7M
$1,150.4M
ACN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for ACN and see if it's the right time to invest.
Dive in

Accenture plc (ACN) Research & Development Expenses (R&D) comparison analysis

General

LTM Research & Development Expenses (R&D)

Growth

Company name

YoY growth

3Y CAGR

5Y CAGR

Accenture plc logo
Accenture plcACN
$0.0
(100.0%)
(100.0%)
(100.0%)
Median Peer Set
$0.0
0.0%
0.0%
0.0%
International Business Machines Corporation logo
International Business Machines CorporationIBM
$5,512.0M
(18.6%)
(5.5%)
(1.6%)
Gartner, Inc. logo
Gartner, Inc.IT
$972.8M
(31.6%)
(3.4%)
(2.8%)
Wipro Limited logo
Wipro LimitedWIT
$51.7M
16.2%
5.4%
1.9%
Infosys Limited logo
Infosys LimitedINFY
$33.8M
4.6%
N/A
N/A
Cognizant Technology Solutions Corporation logo
Cognizant Technology Solutions CorporationCTSH
$0.0
N/A
N/A
N/A
Fiserv, Inc. logo
Fiserv, Inc.FI
$0.0
N/A
N/A
N/A
Fidelity National Information Services, Inc. logo
Fidelity National Information Services, Inc.FIS
$0.0
N/A
N/A
N/A
CGI Inc. logo
CGI Inc.GIB
$0.0
(100.0%)
(100.0%)
(100.0%)
CDW Corporation logo
CDW CorporationCDW
$0.0
N/A
N/A
N/A
Broadridge Financial Solutions, Inc. logo
Broadridge Financial Solutions, Inc.BR
$0.0
N/A
N/A
N/A

ACN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Aug'05Aug'06Aug'07Aug'08Aug'09Aug'10Aug'11Aug'12Aug'13Aug'14Aug'15Aug'16Aug'17Aug'18Aug'19Aug'20Aug'21Aug'22Aug'23Aug'24
Revenue
% growth
17,094.4
13.1%
18,228.4
6.6%
21,452.7
17.7%
25,313.8
18.0%
23,171.0
(8.5%)
23,094.1
(0.3%)
27,352.9
18.4%
29,778.0
8.9%
30,394.3
2.1%
31,874.7
4.9%
32,914.4
3.3%
34,797.7
5.7%
36,765.5
5.7%
41,603.4
13.2%
43,215.0
3.9%
44,327.0
2.6%
50,533.4
14.0%
61,594.3
21.9%
64,111.7
4.1%
64,896.5
1.2%
Cost of Goods Sold (COGS)12,002.213,234.315,411.318,128.216,329.915,843.318,966.220,790.321,010.122,190.223,105.224,520.225,735.029,160.529,900.330,350.934,169.341,892.843,380.143,734.1
Gross Profit
% margin
5,092.2
29.8%
4,994.0
27.4%
6,041.5
28.2%
7,185.6
28.4%
6,841.1
29.5%
7,250.7
31.4%
8,386.7
30.7%
8,987.7
30.2%
9,384.2
30.9%
9,684.5
30.4%
9,809.2
29.8%
10,277.4
29.5%
11,030.5
30.0%
12,442.9
29.9%
13,314.7
30.8%
13,976.2
31.5%
16,364.1
32.4%
19,701.5
32.0%
20,731.6
32.3%
21,162.3
32.6%
Operating Expenses3,070.23,200.93,522.54,151.13,948.04,326.44,914.75,114.55,317.55,402.05,373.45,467.06,397.96,601.97,009.67,462.58,742.610,334.411,921.711,566.5
Research & Development Expenses (R&D)0.00.00.00.00.00.00.00.0715.1639.5625.5643.4704.3790.8799.7870.61,118.31,123.31,298.71,150.4
Selling, General & Administrative Expenses (SG&A)3,070.23,200.93,522.54,151.13,948.04,326.44,914.75,114.55,317.55,402.05,373.45,467.06,397.96,601.97,009.67,462.58,742.610,334.410,858.611,128.0
Operating Income
% margin
2,111.2
12.4%
1,841.1
10.1%
2,492.6
11.6%
3,011.6
11.9%
2,643.9
11.4%
2,914.8
12.6%
3,470.5
12.7%
3,871.5
13.0%
4,338.7
14.3%
4,300.5
13.5%
4,435.9
13.5%
4,810.4
13.8%
4,632.6
12.6%
5,841.0
14.0%
6,305.1
14.6%
6,513.6
14.7%
7,621.5
15.1%
9,367.2
15.2%
8,809.9
13.7%
9,595.8
14.8%
Interest Income0.00.00.0114.649.929.941.142.632.930.434.030.537.956.387.569.333.445.1280.4272.3
Interest Expense0.00.00.022.714.114.715.015.114.017.614.616.315.519.523.033.159.547.347.559.0
Pre-tax Income2,206.01,923.72,618.93,107.82,677.72,914.43,512.03,904.24,339.34,297.74,410.55,603.64,616.05,808.16,251.86,774.37,761.19,196.29,139.39,699.3
Income Tax
% effective tax rate
697.1
31.6%
490.5
25.5%
895.9
34.2%
910.6
29.3%
739.6
27.6%
853.9
29.3%
958.8
27.3%
1,079.2
27.6%
784.8
18.1%
1,121.7
26.1%
1,136.7
25.8%
1,254.0
22.4%
981.1
21.3%
1,593.5
27.4%
1,405.6
22.5%
1,589.0
23.5%
1,770.6
22.8%
2,207.2
24.0%
2,135.8
23.4%
2,280.1
23.5%
Net Income
% margin
940.5
5.5%
973.3
5.3%
1,243.1
5.8%
1,691.8
6.7%
1,590.0
6.9%
1,780.7
7.7%
2,277.7
8.3%
2,553.5
8.6%
3,281.9
10.8%
2,941.5
9.2%
3,053.6
9.3%
4,111.9
11.8%
3,445.1
9.4%
4,059.9
9.8%
4,779.1
11.1%
5,107.8
11.5%
5,906.8
11.7%
6,877.2
11.2%
6,871.6
10.7%
7,264.8
11.2%
EPS1.601.652.062.772.552.793.533.975.084.644.876.585.566.467.498.039.3110.8710.9011.58
Diluted EPS1.561.591.972.652.442.663.403.844.934.524.766.455.446.207.357.899.1610.7110.7711.44
EBITDA
% margin
2,512.0
14.7%
2,113.7
11.6%
3,088.5
14.4%
3,621.9
14.3%
3,190.4
13.8%
3,403.7
14.7%
4,040.3
14.8%
4,512.8
15.2%
4,946.4
16.3%
4,903.2
15.4%
5,071.0
15.4%
6,348.9
18.2%
5,433.4
14.8%
6,754.4
16.2%
7,167.5
16.6%
7,986.1
18.0%
7,621.5
15.1%
10,554.2
17.1%
10,587.6
16.5%
11,188.3
17.2%

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
More ideas -->

FAQ

1) What is Accenture plc's Research & Development Expenses (R&D)?

As of today, Accenture plc's last 12-month Research & Development Expenses (R&D) is $0.0, based on the financial report for Nov 30, 2024 (Q4’2024).

2) What is Accenture plc's Research & Development Expenses (R&D) growth rate?

Over the last year, Accenture plc's Research & Development Expenses (R&D) growth was (100.0%). The average annual Research & Development Expenses (R&D) growth rates for Accenture plc have been (100.0%) over the past three years, (100.0%) over the past five years.

3) Is Accenture plc's Research & Development Expenses (R&D) growth rate Good?

Over the last year, Accenture plc's Research & Development Expenses (R&D) growth was (100.0%), which is lower than industry growth of (0.7%). It indicates that Accenture plc's Research & Development Expenses (R&D) growth is Good.

4) How does Accenture plc's Research & Development Expenses (R&D) growth rate compare to its peers?

Over the last year, Accenture plc's Research & Development Expenses (R&D) growth was (100.0%), which is lower than peer median growth of (100.0%). The list of peers includes IBM, IT, WIT, INFY, CTSH, FI, FIS, GIB, CDW, BR etc.